An Efficacy and Safety Study of PROCRIT (Epoetin Alfa) in Cancer Patients Receiving Chemotherapy Every Week or Every Four Weeks
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Anemia
Related studies linked through entity extraction aliases.
A Study of the Use of PROCRIT (Epoetin Alfa) for the Treatment of Anemia in People With Chronic Kidney Disease Who Live in Long-term Care Facilities.
- Status
- COMPLETED
- Phase
- PHASE2
Treatment of Chronic Anemia With Epoetin Alfa in Elderly
- Status
- UNKNOWN
- Phase
- PHASE2
Well Being of Obstetric Patients on Minimal Blood Transfusions
- Status
- COMPLETED
- Phase
- PHASE4
A Study to Evaluate the Erythropoietic Response in Hepatitis C Virus (HCV) Patients Receiving Combination Ribavirin (RBV)/Interferon (IFN) Therapy or RBV/PEG IFN (NATURAL HISTORY-HCV)
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving First Line Chemotherapy.
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Treatment With NeoRecormon (Epoetin Beta) in Patients With Chronic Renal Anemia
- Status
- COMPLETED
- Phase
- PHASE3
Heme Iron Polypeptide for Iron Deficiency Anemia in Chronic Renal Failure
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Randomized Trial of a Liberal Versus a Restrictive Transfusion Strategy in Elderly Cardiac Surgery Patients
- Status
- COMPLETED
- Phase
- NA
An Open-Label Study to Evaluate the Effect of Every Other Week PROCRIT� (Epoetin Alfa) Dosing (40,000-60,000 Units) On Maintaining Quality of Life and Target Hemoglobin Levels in Anemic HIV-Infected Patients (CHAMPS II)
- Status
- COMPLETED
- Phase
- PHASE4
VIT45 Versus Oral Iron in the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease
- Status
- COMPLETED
- Phase
- PHASE3
Long Term Safety Study of (VIT45) Extension Study: Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease
- Status
- COMPLETED
- Phase
- PHASE3
Hematologic Response of Epoetin Alfa (PROCRIT) Versus Darbepoetin Alfa (ARANESP) in Chemotherapy Induced Anemia
- Status
- COMPLETED
- Phase
- PHASE4
NATURAL HISTORY-Hepatitis C Virus/ Human Immunodeficiency Virus Coinfection
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy and Safety of Peginesatide (AF37702) in the Treatment of Anemia in Participants With Chronic Kidney Disease
- Status
- COMPLETED
- Phase
- PHASE2
Effects of Erythropoietin on Cerebral Vascular Dysfunction and Anemia in Traumatic Brain Injury
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Effects of Early Correction of Anemia in Patients With Chronic Renal Insufficiency
- Status
- TERMINATED
- Phase
- PHASE4
Epoetin Alfa in Advanced Non-Small Cell Lung Cancer (EPO-CAN-20)
- Status
- TERMINATED
- Phase
- PHASE3
A Study to Evaluate PROCRIT (Epoetin Alfa) for Maintenance Phase Treatment of Patients With Anemia Due to Chronic Kidney Disease (PROMPT)
- Status
- COMPLETED
- Phase
- PHASE2
A Study of PROCRIT (Epoetin Alfa) 80,000 Units (U) Once Every Four Weeks (Q4W) vs. 40,000 U Once Every Two Weeks (Q2W) in Cancer Patients Not Receiving Chemotherapy
- Status
- TERMINATED
- Phase
- PHASE2